AG
AGNMF.US Agronomics Limited
- Market cap
- USD 60.7M
- P/E
- -
- P/B
- 0.32x
- ROE
- 28.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2025.
Is AGNMF.US undervalued?
Graham numberThe Graham number of Agronomics Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Agronomics Limited fundamental analysis
No fundamental analysis for Agronomics Limited yet.
Agronomics Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Agronomics Limited
Agronomics Limited is a private equity and venture capital firm specializing in emerging growth, seed/startup, early venture, series B and growth capital investments. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, cultivated meat, technologies, nascent industry of modern foods and materials, biopharma sector and will establish a portfolio of investments in biotechnology and bio…
Full company profileAgronomics Limited financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 1 quarter up to Dec 31, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Agronomics Limited annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | -318K | 181K | 20.8K | -75.0K | 1.28M | 10.7M | 440K | 29.7M | -8.34M | -11.9M | 28.9M |
| Gross Profit | 1.69 | 62.2K | 20.8K | -11.6K | 1.28M | 10.7M | 6.42M | 29.7M | -8.34M | -11.9M | 28.9M |
| Operating Income | -534K | -47.0K | -228K | -301K | 551K | 9.74M | 1.50M | 24.6M | -12.2M | -26.5M | 26.1M |
| EBITDA | 210K | -119K | -212K | -290K | 556K | 2.46M | 22.5K | 24.6M | -10.0M | -26.5M | 40.0M |
| Net Income | -534K | -37.0K | -211K | -289K | 612K | 1.02M | 8.36M | 22.4M | -11.0M | -32.8M | 40.0M |
| EPS | -0.02 | 0.00 | -0.01 | -0.01 | 0.01 | 0.00 | 0.01 | 0.02 | -0.01 | -0.02 | 0.03 |
| Balance Sheet | |||||||||||
| Total Assets | 2.21M | 2.15M | 1.93M | 1.68M | 19.5M | 102M | 146M | 170M | 157M | 125M | 140M |
| Total Liabilities | 54.2K | 30.0K | 23.8K | 65.3K | 131K | 1.62M | 2.49M | 1.95M | 166K | 148K | 235K |
| Shareholders' Equity | 2.15M | 2.12M | 1.90M | 1.61M | 19.4M | 100M | 144M | 168M | 157M | 125M | 140M |
| Cash & Short-term Investments | 2.20M | 1.93M | 1.69M | 1.67M | 19.5M | 101M | 51.5M | 28.1M | 12.2M | 125M | 140M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -190K | -261K | -196K | -181K | -666K | -12.2M | -42.2M | -24.4M | -15.9M | -1.12M | -2.47M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -190K | -261K | -196K | -181K | -666K | -12.2M | -42.2M | -24.4M | -15.9M | -1.12M | -2.47M |
| Ratios | |||||||||||
| ROE | -24.8% | -1.8% | -11.1% | -17.9% | 3.2% | 1.0% | 5.8% | 13.3% | -7.0% | -26.3% | 28.6% |
| ROA | -24.2% | -1.7% | -11.0% | -17.2% | 3.1% | 1.0% | 5.7% | 13.1% | -7.0% | -26.3% | 28.6% |
| Net Profit Margin | - | -20.4% | -1,015.5% | - | 47.9% | 9.6% | 1,898.2% | 75.3% | - | - | 138.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Agronomics Limited dividends
Agronomics Limited has not paid dividends in the last 9 fiscal years.
Who owns Agronomics Limited
- Insiders 18.40%
- Institutions 0.49%
- Public & others 81.11%
- Shares outstanding 1.08B
- Free float 819M
Agronomics Limited company profile
- Company name
- Agronomics Limited
- Ticker
- AGNMF.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Capital Markets
- Fiscal year end
- June
- Address
- Viking House, Ramsey, Isle of Man, IM8 1GB
- Phone
- 44 1624 811454
- Website
- agronomics.im
About Agronomics Limited
Agronomics Limited is a private equity and venture capital firm specializing in emerging growth, seed/startup, early venture, series B and growth capital investments. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, cultivated meat, technologies, nascent industry of modern foods and materials, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. It also seeks to invest in clean food and biomanufacturing. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It makes minority investments in portfolio companies. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. The firm prefers to invest from its balance sheet capital. Agronomics Limited was founded on May 3, 2011 and is based in Ramsey, Isle of Man.
Agronomics Limited management
2- Mr. James Mellon M.A.Co-Founder & Executive Chairperson · born 1957
- Mr. Denham Hervey Newall EkeFinance Director & Executive Director · born 1951